RxDoctor Payments Data

Matthew Fox, MD

Plastic and Reconstructive Surgery · Centerville, OHNPI 1306879218

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,224 of the $2,721 with a category attached, or 81.7%. 19 manufacturers reported payments, led by Integra Lifesciences Corporation at 28.3% of the total.

$2,721in general payments, 2019–2025

Across 82 payments — averaging $33.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$771
  • Acell, Inc.$523
  • Mentor Worldwide LLC$433
  • AbbVie$293
  • Axogen$137
  • Medline Industries LP$121
  • plus $443 from 13 others

What the payments were for

  • Travel & lodging$49718%
  • Food & beverage$2,22482%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,721 in reported general payments places this provider in the 65th percentile of 78 plastic and reconstructive surgery providers in Ohio.

See all plastic and reconstructive surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$66,311
Medicare patients
122
Services billed
475

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen30$193
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim37$109
Methocarbamol16$63
Ondansetron Hcl17$51

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Centerville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →